SCHEMBL17795365

SCHEMBL17795365

CCCCCOc1ccc(S(=O)(=O)C(F)(F)F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRZ1 P23471 1/20 0.59
▸ CA12 O43570 5/20 0.58
▸ CA1 P00915 5/20 0.58
▸ CA2 P00918 5/20 0.58
▸ CA9 Q16790 5/20 0.58
▸ TSHR P16473 3/20 0.58
▸ CA7 P43166 2/20 0.58
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ MAPK1 P28482 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ NR5A1 Q13285 1/20 0.49
▸ TP53 P04637 1/20 0.47
▸ LTA4H P09960 2/20 0.47
▸ PLA2G4B P0C869 1/20 0.46
▸ MMP1 P03956 2/20 0.46
▸ ADAMTS4 O75173 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ MMP13 P45452 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16479592 0.97 PTPRZ1 (0.63) PTPRZ1CA12CA1CA2CA9
SCHEMBL20314687 0.83 PTPRZ1 (0.67) PTPRZ1CA12CA1CA2CA9
SCHEMBL13526773 0.83 PTPRZ1 (0.58) PTPRZ1CA12CA1CA2CA9
SCHEMBL7067575 0.82 RAB9A (0.48) PTPRZ1CA12CA1CA2CA9
SCHEMBL7061028 0.82 RAB9A (0.48) PTPRZ1CA12CA1CA2CA9
SCHEMBL9868562 0.82 CA1 (0.49) PTPRZ1CA12CA1CA2CA9
SCHEMBL931608 0.81 TSHR (0.68) CA12CA1CA2CA9TSHR
Trifluoromethanesulfonic Acid SCHEMBL4619730 0.81 TSHR (0.48) CA12CA1CA2CA9TSHR
Trifluoromethanesulfonic Acid SCHEMBL4618765 0.81 TSHR (0.48) CA12CA1CA2CA9TSHR
SCHEMBL4619978 0.81 CA12 (0.51) CA12CA1CA2CA9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11022884-B2 Silicon-containing resist underlayer film-forming composition having halogenated sulfonylalkyl group NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2021-06-01 — — US disclosed
US-20170168397-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION HAVING HALOGENATED SULFONYLALKYL GROUP NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-06-15 — — US disclosed
US-20160152654-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BioVersys AG (CH) 2016-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152654-A1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PROKR1, ARG1, ARG2 PTPRZ1 4164/4885CA12 4447/4885CA1 3502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback